Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KRYS
#901
Krystal Biotech, Inc. - Common Stock
350.1
6
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.04%
Monthly Change
-3.25%
6 month change
+30.85%
Year Change
+87.12%
Previous Close
357.4
6
Open
350.3
2
Low
349.5
2
High
351.3
6
Volume
64
Markets
US Stock Market
Healthcare
Biotechnology
KRYS
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
22.19 M
25.21 M
25.76 M
28.29 M
28.81 M
29.23 M
29.6 M
Valuation ratios
Enterprise value
1.06 B
1.42 B
1.88 B
3.18 B
4.17 B
6.71 B
10.01 B
Price to earnings ratio
—
-22.35
-14.43
320.41
52.22
36.04
44.23
Price to sales ratio
—
—
28.05 K
68.4
16.04
18.98
24.22
Price to cash flow ratio
—
-32.39
-20.08
39.05
37.75
36.76
39.21
Price to book ratio
—
2.62
3.87
4.45
4.92
6.05
2.14
Enterprise value to EBITDA ratio
-34.1
-21.71
-13.31
-30.71
58.16
40.18
49.09
Profitability ratios
Return on assets %
-0.1
-0.11
-0.25
0.01
0.08
0.15
0.04
Return on equity %
-0.11
-0.12
-0.27
0.01
0.09
0.17
0.04
Return on invested capital %
-411.43
-220.38
-293.7
-156.2
67.23
140.39
32.04
Gross margin %
100
—
100
100
100
100
100
Operating margin %
100 K
—
201.66 K
-216.43
22.61
41.45
49
EBITDA margin %
94.49 K
—
196.13 K
-204.03
24.67
42.92
50.17
Net margin %
97.48 K
—
194.41 K
21.56
30.69
52.64
45.94
Liquidity ratios
Quick ratio
—
—
—
17.55
7.02
9.56
7.96
Current ratio
17.8
17.18
13.3
17.76
7.28
9.95
8.32
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
0
-0
0.07
0.31
0.29
0.08
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-2.16
-3.95
-3.2
4.15
6.71
8.99
EBIT per share
—
-3.08
-5.69
-3.95
2.21
5.39
6.54
EBITDA per share
—
-2.95
-5.54
-3.73
2.41
5.58
6.73
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
19.74
14.88
19.18
20.09
27.64
27.58
Net current asset value per share
—
19.92
15.06
21.18
24.95
34.21
34.56
Tangible book value per share
—
26.74
20.49
28.06
31.82
40.72
44.33
Working capital per share
—
18.77
13.92
19.99
21.52
30.77
30.41
Book value per share
—
26.74
20.49
28.06
31.82
40.72
44.33
News
INmune Bio: CORDStrom In The Lead After Signs Of UK Regulatory Alignment (NASDAQ:INMB)
Interactive Brokers Pops To New High, Leads 13 Hot Prospects Onto Best Stock Lists
Wealth Manager SEI Hits Record High, Leads 13 Newcomers To Best Stock Lists
Hospital Operator Tenet Healthcare Leads 13 To IBD Top Stock Screens
Stock Market Rally Powers Ahead; SpaceX, Palantir, Sandisk Are Key Earnings Movers: Weekly Review
Krystal Q2 Earnings & Sales Beat Estimates, Pipeline in Focus
Amazon Stock, Exelixis And CrowdStrike Among 17 New Stocks On IBD Watchlists
Stocks Settle Sharply Higher as Middle East Tensions Ease
Krystal Biotech, Inc. (KRYS) Q2 2026 Earnings Call Transcript
Read Between These Lines As Eli Lilly, Hot IPO And More Face Key Test
Stocks Rally on Easing Geopolitical Risks and US Economic Strength
Stocks Supported by Easing Middle East Tensions